October Pharma S.A.E (EGX:OCPH)

Market Cap	4.11B +223.8%
Revenue (ttm)	1.46B +22.5%
Net Income	165.09M +11.7%
EPS	13.76 +4.4%
Shares Out	12.00M
PE Ratio	24.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,335
Open	350.62
Previous Close	350.62
Day's Range	341.11 - 356.00
52-Week Range	105.03 - 416.50
Beta	0.72
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides human medicines in the form of capsules, tablets, suppositories, syrup, and drops for internal and sprays and inhalers for external use. October Pharma S.A.E was incorporated in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 25, 2026

Data Sources Report a data error